王雪婷,高雪花,关银,罗延年,连佛彦,何囡囡,李培杰,曹雯. 血降钙素原对脓毒症相关急性肾损伤的诊断价值[J]. 中国急救医学, 2018, 38(1): 80-83.
Wang Xue-ting, Gao Xue-hua, Guan Yin, Luo Yan-nian, Lian Fo-yan, He Nan-nan, Li Pei-jie, Cao Wen. The diagnostic value of procalcitonin (PCT) in patients with sepsis-associated acute kidney injury. Chinese Journal of Critical Care Medicine, 2018, 38(1): 80-83.
[1]Thadhani R, Pascual M, Bonventre JV. Acute renal failure[J]. N Engl J Med, 1996, 334(22): 1448-1460.
[2]Payen D, Lukaszewicz AC, Legrand M, et al. A multicentre study of acute kidney injury in severe sepsis and septic shock: association with inflammatory phenotype and HLA genotype[J]. PLoS One, 2012, 7(6): e35 838.[3]Lerolle N, Nochy D, Guerot E, et al. Histopathology of septic shock induced acute kidney injury: apoptosis and leukocytic infiltration[J]. Intensive Care Med, 2010, 36(3): 471-478.
[4]Bagshaw SM, Uchino S, Bellomo R, et al. Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes[J]. Clin J Am Soc Nephrol, 2007, 2(3): 431-439.
[5]Alobaidi R, Basu RK, Goldstein SL, et al. Sepsis-associated acute kidney injury[J]. Semin Nephrol, 2015, 35(1): 2-11.
[6]Bouadma L, Luyt CE, Tubach F, et al. Use of procalcitonin to reduce patients′ exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial[J]. Lancet, 2010, 375(9713): 463-474.
[7]Jensen JU, Hein L, Lundgren B, et al. procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit:a randomized trial [J]. Crit Care Med, 2011, 39(9): 2048-2058.
[8]Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016[J]. Intensive Care Med, 2017, 43(3):304-377.
[9]Khwaja A. KDIGO clinical practice guidelines for acute kidney injury[J]. Nephron Clin Pract, 2012, 120(4):c179-c184.
[10]方红龙,陈娟,罗建,等.血降钙素原测定对重症脓毒症患者急性肾损伤的预测价值[J]. 医学研究杂志, 2014, 43(5):70-72.
[11]Martensson J, Martling CR, Oldner A, et al. Impact of sepsis on levels of plasma cystatin C in AKI and non-AKI patients[J]. Nephrol Dial Transplant, 2012, 27(2): 576-581.
[12]Harbarth S, Holeckova K, Froidevaux C, et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis[J]. Am J Respir Crit Care Med, 2001,164(3): 396-402.
[13]Kim H, Hur M, Cruz DN, et al. Plasma neutrophil gelatinase associated lipocalin as a biomarker for acute kidney injury in critically ill patients with suspected sepsis[J]. Clin Biochem, 2013, 46(15): 1414-1418.